EDMONTON, Feb. 9, 2012 /CNW Telbec/ - Ceapro Inc. (TSXV: CZO) is pleased to announce that it has retained the services of Renmark Financial Communications Inc. to handle its investor relations activities.
"We are pleased with our achievements in building a solid and profitable company over the last two years and are ready to get this success story known. We are very pleased to announce that we have selected Renmark to reinforce Ceapro's profile in the financial community and enhance the visibility of our project portfolio. We choose Renmark because its standards and methodologies fit best with the message we wish to communicate to the investing public," noted Gilles Gagnon, Acting President & CEO of Ceapro Inc.
In consideration of the services to be provided, the Company has agreed on a month to month agreement starting March 1st, 2012 paying a monthly retainer of $7,000 to Renmark Financial Communications Inc.
Renmark Financial Communications does not have any interest, directly or indirectly, in Ceapro Inc. or its securities, or any right or intent to acquire such an interest.
About Ceapro Inc.
Ceapro Inc. is a Canadian growth-stage biotechnology company. Primary business activities relate to the development and commercialization of natural products for personal care and cosmetic industries using proprietary technology and natural, renewable resources. The commercial line of natural active ingredients include beta glucan, avenanthamides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides. To learn more about Ceapro, visit www.ceapro.com
The TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information:
Chief Financial Officer
Telephone (Edmonton): (780) 917-8376
Email: [email protected]